Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: a Single Center Study

Absztrakt
Leírás
Kulcsszavak
Forrás
Frontiers in Immunology. -13 (2022), p. 1-11. -Front. Immunol. - 1664-3224